BATON ROUGE, La., April 7, 2015 /PRNewswire/ -- Albemarle
Corporation (NYSE: ALB), a leading manufacturer of liquid
curing agents for epoxy, polyurethane and polyurea systems for
coatings, reaction-injection-molded (RIM) parts and other
applications, announced today that it will increase prices on all
shipments globally of Ethacure® 100 products by a minimum of 25%,
effective immediately, or as contracts allow.
The markets that consume these products have shown renewed
strength, and Albemarle is committed to ensuring a reliable product
supply to service customers' needs. This commitment includes
continued investments in manufacturing and appropriate product
testing.
About Albemarle
Albemarle Corporation, headquartered
in Baton Rouge, Louisiana, is a
premier specialty chemicals company with leading positions in
attractive end markets around the world. With a broad customer
reach and diverse end markets, Albemarle develops, manufactures and
markets technologically advanced and high value added products,
including lithium and lithium compounds, bromine and bromine
derivatives, catalysts and surface treatment chemistries used in a
wide range of applications including consumer electronics, flame
retardants, metal processing, plastics, contemporary and
alternative transportation vehicles, refining,
pharmaceuticals, agriculture, construction and custom chemistry
services. Albemarle is focused on delivering differentiated,
performance-based technologies that deliver innovative and
sustainable solutions to its customers. The Company employs
approximately 6,900 people and serves customers in approximately
100 countries. Albemarle regularly posts information to
www.albemarle.com, including notification of events, news,
financial performance, investor presentations and webcasts,
Regulation G reconciliations, SEC filings and other information
regarding the Company, its businesses and the markets it
serves.
"Safe Harbor" Statement under the Private Securities Litigation
Reform Act of 1995: Statements in this press release regarding
Albemarle Corporation's business that are not historical facts are
"forward-looking statements" that involve risks and uncertainties.
For a discussion of such risks and uncertainties, which could cause
actual results to differ from those contained in the
forward-looking statements, see "Risk Factors" in the Company's
Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q.
Logo -
http://photos.prnewswire.com/prnh/20111129/MM14279LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/albemarle-to-increase-price-of-ethacure-100-curatives-300060672.html
SOURCE Albemarle Corporation